Felix Theeuwes
Geen lopende functies
Profiel
Felix Theeuwes is the founder of DURECT Corp., which was founded in 1998.
He held the title of Chairman in 2018.
Dr. Theeuwes also held former positions as a Director at Genetronics Biomedical Corp.
and Inovio Pharmaceuticals, Inc. He was the President-New Ventures at ALZA Corp.
from 1982 to 1998.
Dr. Theeuwes received his undergraduate and graduate degrees from Katholieke Universiteit Leuven.
He also received a doctorate from Katholieke Universiteit Leuven in 1966.
Eerdere bekende functies van Felix Theeuwes
Bedrijven | Functie | Einde |
---|---|---|
DURECT CORPORATION | Oprichter | 31-12-2018 |
INOVIO PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 04-05-2007 |
Genetronics Biomedical Corp. | Directeur/Bestuurslid | 05-04-2005 |
ALZA CORPORATION | Corporate Officer/Principal | 01-08-1998 |
Opleiding van Felix Theeuwes
Katholieke Universiteit Leuven | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DURECT CORPORATION | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Genetronics Biomedical Corp. | Commercial Services |
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |